Combination fixed-dose β agonist and steroid inhaler as required for adults or children with mild asthma: a Cochrane systematic review
<p><strong>Background</strong> In people with mild asthma poor adherence to regular therapy is common and increases the risk of exacerbations, morbidity and mortality. The use of fixed-dose combination inhalers containing an inhaled corticosteroid (ICS) and a fast-acting β2-agonist...
主要な著者: | Crossingham, I, Turner, S, Ramakrishnan, S, Fries, A, Gowell, M, Farhat, Y, Richardson, R, Webb, P, O'Boyle, E, Hinks, TSC |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
BMJ Publishing Group
2021
|
類似資料
-
Combination fixed‐dose beta agonist and steroid inhaler as required for adults or children with mild asthma
著者:: Crossingham, I, 等
出版事項: (2021) -
Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma
著者:: Crossingham, I, 等
出版事項: (2020) -
Azithromycin for mild-to-moderate COVID-19 - Authors' reply
著者:: Hinks, TSC
出版事項: (2021) -
Recovery of Breakthrough Asthma Attacks Treated With Oral Steroids while on monoclonal antibody therapy: protocol for a prospective observational study (BOOST)
著者:: Howell, I, 等
出版事項: (2023) -
Pharmacokinetic optimisation of inhaled steroid therapy in asthma.
著者:: Pavord, I, 等
出版事項: (1993)